Pet Medication Innovation Watch

New & Upcoming Pet Medicines

Track newly FDA-confirmed pet medications and publicly disclosed veterinary medicine development updates. Roxee shows a stage only when public evidence supports it.

Review tracked updates Browse approved medication catalog Talk to a Vet / Find a Vet Near You

Owner-safe availability note

Development-stage products may not be FDA-approved, available, or proven safe/effective. Availability timing is shown only when public source evidence supports it.

Veterinary professional?

Recently FDA-confirmed 76

In development 0

Clinical trial visible 0

Watchlist signals 0

Species

Status

Condition

Evidence

Availability

Clear

Tracked public updates

2 tracked updates

Every card separates FDA-confirmed status from sponsor, trial, regulatory-program, or research signals.

Recently FDA-confirmed FDA-confirmed

CosACTHen®

CosACTHen® / cosyntropin injection

Species: Dogs
Condition: FDA-confirmed approval
Sponsor: Dechra, Ltd.
Public stage: FDA approved
Availability: FDA approved, launch unclear

For the evaluation of adrenal function in dogs.

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Recently FDA-confirmed FDA-confirmed

Otiserene®

Otiserene® / marbofloxacin, terbinafine, and dexamethasone otic suspension

Species: Dogs
Condition: Infection
Sponsor: Dechra, Ltd.
Public stage: FDA approved
Availability: FDA approved, launch unclear

For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs.

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.